Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Charles River Laboratories Cleveland, Inc.
EIR
•Charles River Laboratories Cleveland, Inc.•February 19, 2020

Charles River Laboratories Cleveland, Inc. – FDA EIR, Feb 19, 2020

Record Details

An FDA inspection was conducted at Charles River Laboratories Cleveland, INC., a contract laboratory located in Cleveland, OH, from February 18 to February 19, 2020. This comprehensive inspection, performed under the FDA's 'Drug Manufacturing Inspections' program, covered the firm's systems and operations related to contract laboratory testing. Charles River Laboratories Cleveland provides essential services such as bioassay, potency, and stability-indicating testing for drug products and drug substances, including a specific GMP bioassay for cystic fibrosis transmembrane conductance regulator (CFTR).

The inspection aimed to assess the firm's adherence to relevant regulatory standards for drug manufacturing support. A significant finding of this review was the absence of any significant observations or issues. Consequently, no Form FDA 483, 'Inspectional Observations,' was issued to the company. The facility appeared well-maintained and orderly during the walkthrough. Furthermore, the FDA investigator reviewed the firm's handling of Out-of-Tolerance (OOT) and Out-of-Specification (OOS) investigations, as well as deviations, noting that these processes were being managed effectively, with timely identification of root causes and communication to clients.

Given that no deficiencies or violations were identified, no specific corrective actions or regulatory requirements were mandated by the FDA following this inspection. The inspection concluded with a 'No Action Indicated' classification, signifying satisfactory compliance with applicable regulations.

Company
Charles River Laboratories Cleveland, Inc.
Inspection date
February 19, 2020
Product type
drugs
Office
Cincinnati District Office
Person
  • Jazmine N. Still (Program Analyst)
View Company Profile

ID · e26e5747-9599-4bcc-b494-e3a479986983

Other documents for Charles River Laboratories Cleveland, Inc.
  • EIR - 2010-07-16July 16, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Charles River Laboratories Cleveland, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.